• Justin M. Hall
    3/8/12 10:35A ET: [Short Biotech] Look for a bifurcated market to emerge - like soon. I like Short Nasdaq Biotech (BIS) now at/near $25.
    3/8/12
    Reply (4)
    • Justin M. Hall: Correction, I like BIS at or below $24. My bad. I think Nasdaq Biotech ABE (IBB) has likely peaked or is near peaking this year.
      3/19/12
    • Justin M. Hall: That said, both BIS and IBB might remain rangebound for a couple of months prior to making their respective moves, up or down.
      3/19/12
    • Justin M. Hall: Bottom Line: I like BIS at or below $24. Buy and build this position over time. Don't panic if it falls. Add and stick with it.
      3/19/12
    • Justin M. Hall: NOTE: Avoid playing the IBB puts. They're terribly overpriced and don't represent a good value. Stick with BIS shares.
      3/19/12